Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Neurobiol Dis. 2015 Jun 21;82:254–261. doi: 10.1016/j.nbd.2015.06.012

Figure 1. Scopolamine increases Fos+ immunoreactivity in the mPFC.

Figure 1

The influence of scopolamine administration (25 µg/kg, i.p.) on Fos+ immunoreactivity in mPFC of rat was determined 1 hr after drug treatment. Shown in the panels to the left are representative images from vehicle and scopolamine treated animals demonstrating induction of Fos+ neurons in the PrL and IL. The number of Fos+ neurons was analyzed and the results are show in the bar graphs to the right for each region. The results are the mean ± S.E.M. of 6 rats per group. * p < 0.01 compared to vehicle (Student’s t-test).

HHS Vulnerability Disclosure